Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 221240 of 20,252 grants

Active NON-SBIR/STTR RPGS
Integrative Multiomics and Clinical Laboratory Translation for Advanced, Rare, and Pediatric Cancers
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

ABSTRACT The project aims to incorporate emerging technologies in genomics, transcriptomics, epigenomics and proteomics for the analyses of advanced, rare, and pediatric cancers. T...

$1.6M
USD
Active NON-SBIR/STTR RPGS
Quantitative in vivo dosimetry for radiotherapy using model-based X-ray-induced acoustic computed tomography
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2024 – 2029

Abstract Accurate dose delivery at the tumor site is crucial for the success of radiotherapy (RT) for cancer treatment. However, as yet there are no techniques in clinics with the...

$802.3K
USD
Active NON-SBIR/STTR RPGS
Leveraging Observational (Real World) Data to Advance Precision Oncology
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

OVERALL ABSTRACT Leveraging Observational (Real World) Data to Advance Precision Oncology Principal Investigator: Charles Sawyers, Memorial Sloan Kettering Cancer Center Precision...

$23.72M
USD
Active NON-SBIR/STTR RPGS
Project 1: Overcoming methodologic barriers to analysis of observational clinico-genomic data in oncology
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT 1 ABSTRACT Overcoming methodologic barriers to analysis of observational clinico-genomic data in oncology Project Leaders: Kenneth Kehl (DFCI); Deborah Schrag (MSK) Precisi...

Active NON-SBIR/STTR RPGS
Project 2: Integrating race, ethnicity, and genomic ancestry across GENIE to understand genetic and environmental contributions to pan-cancer risk, prognosis, and outcomes
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT 2 ABSTRACT Integrating race, ethnicity, and genomic ancestry across GENIE to understand genetic and environmental contributions to pan-cancer risk, prognosis, and outcomes....

Active NON-SBIR/STTR RPGS
Project 3: Predictors of sensitivity to immunotherapy and targeted treatments based on real world evidence
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT 3 ABSTRACT Predictors of sensitivity to immunotherapy and targeted treatments based on real world evidence Project Leaders: Phillipe Bedard (Princess Margaret); Nikolaus Sc...

Active NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

CORE C ABSTRACT Administrative Core Core Leader: Charles Sawyers (MSK) The P01 Administrative Core will provide the organizational support and leadership necessary to support the s...

Active NON-SBIR/STTR RPGS
PET Biomarker for synaptic density changes after radiation therapy
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2024 – 2028

Project Summary/Abstract: Whole brain synaptic density imaging with quantitative positron emission tomography (PET) has demonstrated critical insights into understanding of neurode...

$7.37M
USD
Completed SBIR-STTR RPGS
Multifunctional EPRI Instrument to Advance Therapies in Biomedical Sciences
NATIONAL CANCER INSTITUTE O2M Technologies, Llc United States 2024 – 2025

Abstract: Electron paramagnetic resonance imaging (EPRI), where electron spins are the subject of the investigation, is a promising tool and has the ability to provide maps of mult...

$4M
USD
Active NON-SBIR/STTR RPGS
Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Project Summary: For >18-years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, defi...

$6.32M
USD
Completed SBIR-STTR RPGS
Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal Nanoparticles
NATIONAL CANCER INSTITUTE Immunoblue, Llc United States 2024 – 2025

PROJECT SUMMARY The goal of this STTR Phase I application is to establish the feasibility of commercializing a personalized and multi-targeted adoptive T cell therapy (ATCT) for gl...

$4M
USD
Active RESEARCH CENTERS
Project 3 - Deciphering the Role of the Translational Oncogenic Program in Prostate Cance
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT – PROJECT 3 (RUGGERO): DECIPHERING THE ROLE OF THE TRANSLATIONAL ONCOGENIC PROGRAM IN PROSTATE CANCER While the approved treatments for castrate-resistant...

Active RESEARCH CENTERS
Core 1 - Biostatistics and Bioinformatics Core (BBC)
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT – CORE 1 - BIOSTATISTICS AND BIOINFORMATICS CORE (BBC) The goal of the Biostatistics and Bioinformatics Core (BBC) is to collaborate with SPORE Investigato...

Active RESEARCH CENTERS
Core 2 - Prostate Tissue Core (PTC)
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY - CORE 2 : PROSTATE TISSUE CORE (PTC) The Prostate Tissue Core (PTC) is the organizing structure managing human tissue, biospecimens and pathology resources of the...

Active RESEARCH CENTERS
Developmental Research Program (DRP)
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT – DEVELOPMENTAL RESEARCH PROGRAM – (DRP) The fundamental objective of the Developing Research Program (DRP) proposed in this SPORE application, is to ident...

Active RESEARCH CENTERS
Career Enhancement Program (CEP)
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT – CAREER ENHANCEMENT PROGRAM – (CEP) The goal of the Career Enhancement Program (CEP) is to recruit promising investigators, at any level of their career,...

Active OTHER RESEARCH-RELATED
Biomarker-Driven Strategies to Overcome Immunotherapy Resistance in STK11-Deficient NSCLC
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

SUMMARY Despite significant advances in Immuno-Oncology (IO) treatments, lung cancers with loss-of-function mutations in STK11, comprising 20-30% of cases, demonstrate poor prognos...

$2.81M
USD
Completed SBIR-STTR RPGS
Development of an Innovative PSMA-Targeted Small Molecule Prodrug for Prostate Cancer
NATIONAL CANCER INSTITUTE Cancer Targeted Technology, Llc United States 2024 – 2025

ABSTRACT Prostate cancer (PCa) is the most commonly diagnosed cancer and second leading cause of cancer death in American men.1 For metastatic castration resistant prostate cancer...

$4M
USD
Active NON-SBIR/STTR RPGS
Development of integrated risk models of genetic and non-genetic risk factors in endometrial cancer across diverse ancestries
NATIONAL CANCER INSTITUTE Feinstein Institute for Medical Research United States 2024 – 2026

PROJECT SUMMARY The incidence of Endometrial Cancer (EC) has been rising, with a notable increase in mortality rates, especially among Black women who face a higher risk of aggress...

$4.56M
USD
Active RESEARCH CENTERS
UCSF Specialized Programs of Research Excellence (SPOREs) in Prostate Cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY / ABSTRACT – OVERALL Prostate cancer is the second leading cause of cancer deaths of men in the United States and places a significant health burden on society. The...

$22.04M
USD